Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Mercedes Santoro

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Antimicrobial Resistance and Infection Control|August 27, 2020
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimensJoseph Fokam, Desire Takou, Ezechiel Ngoufack Jagni Semengue, et al.
Plos One|October 25, 2023
HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort studyWilly Le Roi Togna Pabo, Joseph Fokam, Debimeh Njume, et al.
Sexually Transmitted Infections|May 12, 2019
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in ItalyLavinia Fabeni, Claudia Alteri, Giulia Berno, et al.
Journal of Global Antimicrobial Resistance|August 18, 2016
The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitroClaudia Alteri, Matteo Surdo, Velia Chiara Di Maio, et al.
The Journal of Pediatrics|January 18, 2024
Characterization of HIV-1 Reservoirs in Children and Adolescents: A Systematic Review and Meta-Analysis Toward Pediatric HIV CureAude Christelle Ka'e, Maria Mercedes Santoro, Aubin Nanfack, et al.
The New Microbiologica|November 17, 2015
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim ProjectMassimo Andreoni, Simone Marcotullio, Vincenzo Puro, et al.
The Journal of Infection|December 3, 2014
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infectionCarmen Mirabelli, Matteo Surdo, Formijn Van Hemert, et al.
Viruses|January 25, 2025
Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income CountriesAlex Durand Nka, Yagai Bouba, Wilfried Rooker Tsapi Lontsi, et al.
Viruses|April 30, 2021
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1bMohammad Alkhatib, Velia Chiara Di Maio, Valentina De Murtas, et al.
Frontiers in Medicine|October 7, 2024
Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-studyWilly Le Roi Togna Pabo, Aurelie Minelle Kengni Ngueko, Alex Durand Nka, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Antimicrobial Resistance and Infection Control|August 27, 2020
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimensJoseph Fokam, Desire Takou, Ezechiel Ngoufack Jagni Semengue, et al.
Plos One|October 25, 2023
HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort studyWilly Le Roi Togna Pabo, Joseph Fokam, Debimeh Njume, et al.
Sexually Transmitted Infections|May 12, 2019
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in ItalyLavinia Fabeni, Claudia Alteri, Giulia Berno, et al.
Journal of Global Antimicrobial Resistance|August 18, 2016
The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitroClaudia Alteri, Matteo Surdo, Velia Chiara Di Maio, et al.
The Journal of Pediatrics|January 18, 2024
Characterization of HIV-1 Reservoirs in Children and Adolescents: A Systematic Review and Meta-Analysis Toward Pediatric HIV CureAude Christelle Ka'e, Maria Mercedes Santoro, Aubin Nanfack, et al.
The New Microbiologica|November 17, 2015
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim ProjectMassimo Andreoni, Simone Marcotullio, Vincenzo Puro, et al.
The Journal of Infection|December 3, 2014
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infectionCarmen Mirabelli, Matteo Surdo, Formijn Van Hemert, et al.
Viruses|January 25, 2025
Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income CountriesAlex Durand Nka, Yagai Bouba, Wilfried Rooker Tsapi Lontsi, et al.
Viruses|April 30, 2021
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1bMohammad Alkhatib, Velia Chiara Di Maio, Valentina De Murtas, et al.
Frontiers in Medicine|October 7, 2024
Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-studyWilly Le Roi Togna Pabo, Aurelie Minelle Kengni Ngueko, Alex Durand Nka, et al.
Pageof 14